Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Inks Drug-Discovery Collaboration with Chinese Drug-Screening Concern

NEW YORK , Oct. 31 (GenomeWeb News) - Invitrogen will provide its drug-discovery technologies to the National Center for Drug Screening, a Shanghai-based public technology organization that specializes in screening new drugs in China, the company said today.

 

The deal calls for Invitrogen to contribute drug-discovery technologies such as GeneBlazer and Polar Screen, and to help the NationalCenter for Drug Screening develop new assays and techniques specific to the collaboration, the company said.

 

Specific terms of the arrangement were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.